SCHEMBL31744779

SCHEMBL31744779

Brc1ccc2[nH]cc(Cc3nc4ccccc4s3)c2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.57
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
HTT P42858 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
HTR2A P28223 1/20 0.46
TRPM8 Q7Z2W7 1/20 0.46
CSNK2A1 P68400 1/20 0.45
AKR1B1 P15121 2/20 0.44
PTPN1 P18031 1/20 0.42
HTR1A P08908 2/20 0.42
SLC6A4 P31645 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL1598780 0.77 KMT2A (0.49) GPR84MEN1KMT2AMAPTKDM4E
SCHEMBL147202 0.76 NPC1 (0.54) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL155490 0.76 NPC1 (0.54) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL27929625 0.75 GPR84 (1.00) GPR84MEN1KMT2AMAPTHTR2A
SCHEMBL31744667 0.74 GPR84 (0.83) GPR84MEN1KMT2AMAPTHTR2A
SCHEMBL19490296 0.73 GPR84 (0.61) GPR84HTR2ATRPM8CSNK2A1HTR1A
SCHEMBL6575586 0.73 GPR84 (0.58) GPR84MEN1KMT2AMAPTKDM4E
SCHEMBL22802291 0.73 IDO1 (0.50) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL31744868 0.73 NPC1 (0.48) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL6577863 0.73 GPR84 (0.58) GPR84MEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US claimed
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 GPR84 4183/4885MEN1 2402/4885KMT2A 4633/4885
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 GPR84 4183/4885MEN1 2402/4885KMT2A 4633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.